Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules

Park,Hyun Ah; Kwon,Ok‑Kyoung; Ryu,Hyung Won; Min,Jae‑Hong; Park,Min‑Woo; Park,Mi‑Hyeong; Paik,Jin‑Hyub; Choi,Sangho; Paryanto,Imam; Yuniato,Prasetyawan; Oh,Sei‑Ryang; Ahn,Kyung‑Seop; Lee,Jae‑Won

doi:10.3892/ijmm.2019.4110

Physalis peruviana L. inhibits ovalbumin‑induced airway inflammation by attenuating the activation of NF‑κB and inflammatory molecules

Authors:
- Hyun Ah Park
- Ok‑Kyoung Kwon
- Hyung Won Ryu
- Jae‑Hong Min
- Min‑Woo Park
- Mi‑Hyeong Park
- Jin‑Hyub Paik
- Sangho Choi
- Imam Paryanto
- Prasetyawan Yuniato
- Sei‑Ryang Oh
- Kyung‑Seop Ahn
- Jae‑Won Lee
View Affiliations

Affiliations: Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Chungcheongbuk 28160, Republic of Korea, SciTech Korea Inc., Seoul 01138, Republic of Korea, Laboratory Animal Resources Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong Health Technology Administration Complex, Cheongju, Chungcheongbuk 28159, Republic of Korea, International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea, Center for Pharmaceutical and Medical Technology, the Agency for the Assessment and Application of Technology, Tangerang, Banten 15314, Indonesia
Published online on: February 26, 2019 https://doi.org/10.3892/ijmm.2019.4110
Pages: 1830-1838
Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Physalis peruviana L. (PP) is well known for its various properties, including its antioxidant property. In our previous study, the protective effects of PP against cigarette smoke‑induced airway inflammation were confirmed. The purpose of the present study was to evaluate the anti‑inflammatory effect of PP against ovalbumin (OVA)‑induced airway inflammation. Treatment with PP inhibited the numbers of eosinophils and the levels of inflammatory cytokines, including interleukin (IL)‑4, IL‑5 and IL‑13, in the bronchoalveolar lavage fluid (BALF) of animal models with OVA‑induced allergic asthma. PP also significantly decreased the production of total immunoglobulin E in the serum. Lung sections stained with hematoxylin and eosin revealed that the influx of inflammatory cells was decreased in the lungs of mice treated with PP compared with cells in the OVA group. The increased expression levels of monocyte chemoattractant protein‑1 (MCP‑1) and T cell marker KEN‑5 were also reduced following PP treatment in the lung tissues compared with those in the OVA group. The PAS staining results showed that PP attenuated the overproduction of mucus in the lung. Additionally, western blot analysis revealed that PP significantly downregulated the activation of nuclear factor‑κB/p38 mitogen‑activated protein kinase/c‑Jun N‑terminal kinase, and upregulated the expression of heme oxgenase‑1 in the lungs. In an in vitro experiment, PP effectively reduced the levels of LPS‑stimulated MCP‑1 in a concentration‑dependent manner. Taken together, these results indicate that PP has considerable potential in the treatment of allergic asthma.

View Figures

View References

1	Qian J, Ma X, Xun Y and Pan L: Protective effect of forsythiaside A on OVA-induced asthma in mice. Eur J Pharmacol. 812:250–255. 2017. View Article : Google Scholar : PubMed/NCBI
2	Liu J, Wei Y, Luo Q, Xu F, Zhao Z, Zhang H, Lu L, Sun J, Liu F, Du X, et al: Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21. Int J Mol Med. 38:1541–1548. 2016. View Article : Google Scholar : PubMed/NCBI
3	Ntontsi P, Papathanassiou E, Loukides S, Bakakos P and Hillas G: Targeted anti-IL-13 therapies in asthma: Current data and future perspectives. Expert Opin Investig Drugs. 27:179–186. 2018. View Article : Google Scholar : PubMed/NCBI
4	Gu X, Zhang Q, Du Q, Shen H and Zhu Z: Pinocembrin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice. Int Immunopharmacol. 53:90–95. 2017. View Article : Google Scholar : PubMed/NCBI
5	Ji P, Hu H, Yang X, Wei X, Zhu C, Liu J, Feng Y, Yang F, Okanurak K, Li N, et al: AcCystatin, an immunoregulatory molecule from Angiostrongylus cantonensis, ameliorates the asthmatic response in an aluminium hydroxide/ovalbumin-induced rat model of asthma. Parasitol Res. 114:613–624. 2015. View Article : Google Scholar
6	Rajajendram R, Tham CL, Akhtar MN, Sulaiman MR and Israf DA: Inhibition of epithelial CC-Family chemokine synthesis by the synthetic chalcone DMPF-1 via disruption of NF-κB nuclear translocation and suppression of experimental asthma in mice. Mediators Inflamm. 2015.176926:2015.
7	Lian Q, Jiang W, Cheng Y, Cao H, Liu M, Wang J, Li Y, Song X and Wang F: A novel pentapeptide originated from calf thymus named TIPP shows an inhibitory effect on lung allergic inflammation. Int Immunopharmacol. 24:256–266. 2015. View Article : Google Scholar
8	Zhang Q, Wang L, Chen B, Zhuo Q, Bao C and Lin L: Propofol inhibits NF-κB activation to ameliorate airway inflammation in ovalbumin (OVA)-induced allergic asthma mice. Int Immunopharmacol. 51:158–164. 2017. View Article : Google Scholar : PubMed/NCBI
9	Duan W, Chan JH, Wong CH, Leung BP and Wong WS: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol. 172:7053–7059. 2004. View Article : Google Scholar : PubMed/NCBI
10	Duan W and Wong WS: Targeting mitogen-activated protein kinases for asthma. Curr Drug Targets. 7:691–698. 2006. View Article : Google Scholar : PubMed/NCBI
11	Ye P, Yang XL, Chen X and Shi C: Hyperoside attenuates OVA-induced allergic airway inflammation by activating Nrf2. Int Immunopharmacol. 44:168–173. 2017. View Article : Google Scholar : PubMed/NCBI
12	Shen ML, Wang CH, Lin CH, Zhou N, Kao ST and Wu DC: Luteolin Attenuates Airway Mucus Overproduction via Inhibition of the GABAergic System. Sci Rep. 6:327562016. View Article : Google Scholar : PubMed/NCBI
13	Shin NR, Ryu HW, Ko JW, Park SH, Yuk HJ, Kim HJ, Kim JC, Jeong SH and Shin IS: Artemisia argyi attenuates airway inflammation in ovalbumin-induced asthmatic animals. J Ethnopharmacol. 209:108–115. 2017. View Article : Google Scholar : PubMed/NCBI
14	Osorio-Guarín JA, Enciso-Rodríguez FE, González C, Fernández-Pozo N, Mueller LA and Barrero LS: Association analysis for disease resistance to Fusarium oxysporum in cape gooseberry (Physalis peruviana L). BMC Genomics. 17:2482016. View Article : Google Scholar : PubMed/NCBI
15	Wu SJ, Tsai JY, Chang SP, Lin DL, Wang SS, Huang SN and Ng LT: Supercritical carbon dioxide extract exhibits enhanced antioxidant and anti-inflammatory activities of Physalis peruviana. J Ethnopharmacol. 108:407–413. 2006. View Article : Google Scholar : PubMed/NCBI
16	Franco LA, Matiz GE, Calle J, Pinzon R and Ospina LF: Antiinflammatory activity of extracts and fractions obtained from Physalis peruviana L. calyces. Biomedica. 27:110–115. 2007.in Spanish. View Article : Google Scholar : PubMed/NCBI
17	Castro J, Ocampo Y and Franco L: Cape Gooseberry [Physalis peruviana L.] Calyces Ameliorate TNBS Acid-induced Colitis in Rats. J Crohn's Colitis. 9:1004–1015. 2015. View Article : Google Scholar
18	Park HA, Lee JW, Kwon OK, Lee G, Lim Y, Kim JH, Paik JH, Choi S, Paryanto I, Yuniato P, et al: Physalis peruviana L. inhibits airway inflammation induced by cigarette smoke and lipopolysaccharide through inhibition of extracellular signal-regulated kinase and induction of heme oxygenase-1. Int J Mol Med. 40:1557–1565. 2017. View Article : Google Scholar : PubMed/NCBI
19	Jeon CM, Shin IS, Shin NR, Hong JM, Kwon OK, Kim HS, Oh SR, Myung PK and Ahn KS: Siegesbeckia glabrescens attenuates allergic airway inflammation in LPS-stimulated RAW 264.7 cells and OVA induced asthma murine model. In t. Immunopharmacol. 22:414–419. 2014. View Article : Google Scholar
20	Lee JW, Park JW, Shin NR, Park SY, Kwon OK, Park HA, Lim Y, Ryu HW, Yuk HJ, Kim JH, et al: Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury. Int J Mol Med. 38:834–844. 2016. View Article : Google Scholar : PubMed/NCBI
21	Kupczyk M and Kuna P: Benralizumab: An anti-IL-5 receptor α monoclonal antibody in the treatment of asthma. Immunotherapy. 10:349–359. 2018. View Article : Google Scholar : PubMed/NCBI
22	Deo SS, Mistry KJ, Kakade AM and Niphadkar PV: Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India. 27:66–71. 2010. View Article : Google Scholar : PubMed/NCBI
23	Xu W, Hu M, Zhang Q, Yu J and Su W: Effects of anthraquinones from Cassia occidentalis L. on ovalbumin-induced airways inflammation in a mouse model of allergic asthma. J Ethnopharmacol. 221:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
24	Ma Y, Tang T, Sheng L, Wang Z, Tao H, Zhang Q, Zhang Y and Qi Z: Aloin suppresses lipopolysaccharide induced inflammation by inhibiting JAK1 STAT1/3 activation and ROS production in RAW264.7 cells. Int J Mol Med. 42:1925–1934. 2018.PubMed/NCBI
25	Lee JW, Seo KH, Ryu HW, Yuk HJ, Park HA, Lim Y, Ahn KS and Oh SR: Anti-inflammatory effect of stem bark of Paulownia tomentosa Steud. in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and LPS-induced murine model of acute lung injury. J Ethnopharmacol. 210:23–30. 2018. View Article : Google Scholar
26	Gao Y, Zhaoyu L, Xiangming F, Chunyi L, Jiayu P, Lu S, Jitao C, Liangcai C and Jifang L: Abietic acid attenuates allergic airway inflammation in a mouse allergic asthma model. Int Immunopharmacol. 38:261–266. 2016. View Article : Google Scholar : PubMed/NCBI
27	Xu J, Zhu YT, Wang GZ, Han D, Wu YY, Zhang DX, Liu Y, Zhang YH, Xie XM, Li SJ, et al: The PPARγ agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma. Acta Pharmacol Sin. 36:171–178. 2015. View Article : Google Scholar : PubMed/NCBI
28	Wang C, Choi YH, Xian Z, Zheng M, Piao H and Yan G: Aloperine suppresses allergic airway inflammation through NF-κB, MAPK, and Nrf2/HO-1 signaling pathways in mice. Int Immunopharmacol. 65:571–579. 2018. View Article : Google Scholar : PubMed/NCBI
29	Kim YH, Choi YJ, Kang MK, Park SH, Antika LD, Lee EJ, Kim DY and Kang YH: Astragalin inhibits allergic inflammation and airway thickening in ovalbumin-challenged mice. J Agric Food Chem. 65:836–845. 2017. View Article : Google Scholar : PubMed/NCBI
30	Fang P, Shi HY, Wu XM, Zhang YH, Zhong YJ, Deng WJ, Zhang YP and Xie M: Targeted inhibition of GATA-6 attenuates airway inflammation and remodeling by regulating caveolin-1 through TLR2/MyD88/NF-κB in murine model of asthma. Mol Immunol. 75:144–150. 2016. View Article : Google Scholar : PubMed/NCBI
31	Wardlaw AJ, Brightling C, Green R, Woltmann G and Pavord I: Eosinophils in asthma and other allergic diseases. Br Med Bull. 56:985–1003. 2000. View Article : Google Scholar
32	Venturini CL, Macho A, Arunachalam K, de Almeida DAT, Rosa SIG, Pavan E, Balogun SO, Damazo AS and Martins DTO: Vitexin inhibits inflammation in murine ovalbumin-induced allergic asthma. Biomed Pharmacother. 97:143–151. 2018. View Article : Google Scholar
33	Byrne AJ, Jones CP, Gowers K, Rankin SM and Lloyd CM: Lung macrophages contribute to house dust mite driven airway remodeling via HIF-1α. PLoS One. 8:e692462013. View Article : Google Scholar
34	Poston RN, Chanez P, Lacoste JY, Litchfield T, Lee TH and Bousquet J: Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis. 145:918–921. 1992. View Article : Google Scholar : PubMed/NCBI
35	Li R, Wang J, Zhu F, Li R, Liu B, Xu W, He G, Cao H, Wang Y and Yang J: HMGB1 regulates T helper 2 and T helper17 cell differentiation both directly and indirectly in asthmatic mice. Mol Immunol. 97:45–55. 2018. View Article : Google Scholar : PubMed/NCBI
36	Hao W, Wang J, Zhang Y, Wang Y, Sun L and Han W: Leptin positively regulates MUC5AC production and secretion induced by interleukin-13 in human bronchial epithelial cells. Biochem Biophys Res Commun. 493:979–984. 2017. View Article : Google Scholar : PubMed/NCBI
37	Licari A, Castagnoli R, Panfili E, Marseglia A, Brambilla I and Marseglia GL: An update on anti-IgE therapy in pediatric respiratory diseases. Curr Respir Med Rev. 13:22–29. 2017. View Article : Google Scholar :
38	Bax HJ, Keeble AH and Gould HJ: Cytokinergic IgE action in mast cell activation. Front Immunol. 3:2292012. View Article : Google Scholar : PubMed/NCBI
39	Song YD, Li XZ, Wu YX, Shen Y, Liu FF, Gao PP, Sun L and Qian F: Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model. Acta Pharmacol Sin. 39:1317–1325. 2018. View Article : Google Scholar : PubMed/NCBI
40	Schneider D, Hong JY, Bowman ER, Chung Y, Nagarkar DR, McHenry CL, Goldsmith AM, Bentley JK, Lewis TC and Hershenson MB: Macrophage/epithelial cell CCL2 contributes to rhinovirus-induced hyperresponsiveness and inflammation in a mouse model of allergic airways disease. Am J Physiol Lung Cell Mol Physiol. 304:L162–L169. 2013. View Article : Google Scholar :
41	Nguyen TH, Maltby S, Simpson JL, Eyers F, Baines KJ, Gibson PG, Foster PS and Yang M: TNF-α and macrophages are critical for respiratory syncytial virus-induced exacerbations in a mouse model of allergic airways disease. J Immunol. 196:3547–3558. 2016. View Article : Google Scholar : PubMed/NCBI
42	Lillehoj ER and Kim KC: Airway mucus: Its components and function. Arch Pharm Res. 25:770–780. 2002. View Article : Google Scholar
43	Evans CM, Kim K, Tuvim MJ and Dickey BF: Mucus hypersecretion in asthma: Causes and effects. Curr Opin Pulm Med. 15:4–11. 2009. View Article : Google Scholar :
44	Xiong YY, Wang JS, Wu FH, Li J and Kong LY: The effects of (±)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-β1/Smad signaling pathway in a murine model of allergic asthma. Int Immunopharmacol. 14:392–400. 2012. View Article : Google Scholar : PubMed/NCBI
45	Huang W, Li ML, Xia MY and Shao JY: Fisetin-treatment alleviates airway inflammation through inhbition of MyD88/NF-κB signaling pathway. Int J Mol Med. 42:208–218. 2018.PubMed/NCBI
46	Wei DZ, Guo XY, Lin LN, Lin MX, Gong YQ, Ying BY and Huang MY: Effects of Angelicin on Ovalbumin (OVA)-Induced Airway Inflammation in a Mouse Model of Asthma. Inflammation. 39:1876–1882. 2016. View Article : Google Scholar : PubMed/NCBI
47	Yoon SC, Je IG, Cui X, Park HR, Khang D, Park JS, Kim SH and Shin TY: Anti-allergic and anti-inflammatory effects of aqueous extract of Pogostemon cablin. Int J Mol Med. 37:217–224. 2016. View Article : Google Scholar
48	Wijerathne CUB, Seo CS, Song JW, Park HS, Moon OS, Won YS, Kwon HJ and Son HY: Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. Int Immunopharmacol. 49:67–76. 2017. View Article : Google Scholar : PubMed/NCBI